Article
CDKN3 mRNA as a Biomarker for Survival and Therapeutic Target in Cervical Cancer
15 Sept 2015
Abstract excerpt
The cyclin-dependent kinase inhibitor 3 (CDKN3) gene, involved in mitosis, is upregulated in cervical cancer (CC). We investigated CDKN3 mRNA as a survival biomarker and potential therapeutic target for CC. CDKN3 mRNA was measured in 134 CC and 25 controls by quantitative PCR. A 5-year survival study was conducted in 121 of these CC patients. Furthermore, CDKN3-specific siRNAs were used to investigate whether...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
